On September 16, the State Medical Insurance Bureau officially announced the guiding opinions on the establishment of medical price and credit evaluation system for bidding and purchasing. According to the opinion, we will adhere to the innovation of medical price governance, and establish a pharmaceutical price and bidding credit evaluation system with equal rights and responsibilities, coordination and linkage based on the purchase and sale contract relationship in the centralized procurement of drugs and medical consumables, relying on the bidding and procurement platform for drugs and medical consumables, and systematically integrating mechanisms such as trustworthy commitment, credit rating, hierarchical disposal, and credit repair